The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A new study among people entering prison in the USA suggests ‘opt-out’ testing approaches for HIV and hepatitis C virus (HCV) may need reconsideration.
As prescription opioid addiction continues to increase in the USA – researchers predict a rising epidemic of injecting-related diseases such as HIV and hepatitis.
Authorities in the Czech Republic have dropped their case against 30 HIV-positive gay men accused of having unprotected sex and spreading HIV – a criminal offence in the country.
The world’s largest drug consumption facility has opened in Copenhagen, Denmark, giving people who use drugs a safe place to use illicit substances in a way that will limit harm to themselves, and to those around them.
The UK High Court has today ruled that the National Health Service (NHS) England can legally provide the game-changing HIV prevention drug, Truvada, as a pre-exposure prophylaxis (PrEP) to HIV negative people most at risk of HIV – but only if it chooses to.
Prevalence of hepatitis C (HCV) among people who inject drugs in Europe is very high – in excess of 50% across six countries in the region and an estimated 84% in Portugal. But a new report released by EU drug body for World Hepatitis Day (July 28), shows that a combination of new treatments and prevention interventions gives significant reason for optimism in curbing the HCV epidemic among drug users in the region.
An injectable version of the opiate substitution treatment (OST) buprenorphine – which is delivered through an implant – has been approved for use in the USA by the Food and Drug Administration (FDA).
The number of new HIV infections in the USA has fallen by 11% between 2010 and 2015, however the rate of decline falls far short of the goals set in the 2010-2015 National HIV/AIDS Strategy (NHAS).